$4.52 -0.11 (%) MannKind Corp - NASDAQ

May. 22, 2015 | 04:00 PM

Partner Headlines

  1. Wall Street Analysts Sell The Bottom In MannKind

    Benzinga | May. 19, 2015 | 14:04PM EST
  2. Benzinga's Top #PreMarket Gainers

    Benzinga | May. 19, 2015 | 08:08AM EST
  3. MannKind Corporation Disappoints with Afrezza Sales; Analysts Lower Expectations

    GuruFocus | May. 11, 2015 | 16:24PM EST
  4. Mid-Day Market Update: U.S. Stocks Mostly Lower; Rosetta Resources Shares Rise On Acquisition News

    Benzinga | May. 11, 2015 | 13:13PM EST
  5. Mid-Morning Market Update: Markets Edge Higher; Dean Foods Earnings Beat Views

    Benzinga | May. 11, 2015 | 10:14AM EST
  6. Benzinga's Top #PreMarket Losers

    Benzinga | May. 11, 2015 | 08:26AM EST
  7. MannKind Looks Good For Long Term Investors

    GuruFocus | Apr. 29, 2015 | 12:37PM EST
  8. MannKind to Manufacture 12 Unit Cartridge Strength of AFREZZA(R) Following FDA Approval

    Benzinga | Apr. 27, 2015 | 09:01AM EST
  9. Goldman Sachs Slams MannKind, Shares Down 9%

    Benzinga | Mar. 3, 2015 | 11:52AM EST
  10. MannKind's Short Interest Has 'Grown High,' Analyst Says

    Benzinga | Mar. 3, 2015 | 10:47AM EST
  11. Goldman Sachs Says MannKind Has 55% Downside

    Benzinga | Mar. 3, 2015 | 10:07AM EST
  12. Morning Market Losers

    Benzinga | Mar. 3, 2015 | 10:02AM EST
  13. Benzinga's Top #PreMarket Losers

    Benzinga | Mar. 3, 2015 | 08:23AM EST
  14. Jefferies Expects Exciting 2015 For MannKind

    Benzinga | Feb. 26, 2015 | 10:56AM EST
  15. JPM Securities Picks Through Biotech News For Winners

    Benzinga | Feb. 25, 2015 | 12:41PM EST
  16. MannKind's Accounting Is 'Murky,' MLV Analyst Says

    Benzinga | Feb. 25, 2015 | 10:15AM EST
  17. MannKind Corporation Posts In-Line Q4; Expense Falls 35%

    Benzinga | Feb. 24, 2015 | 17:34PM EST
  18. Earnings Scheduled For February 24, 2015

    Benzinga | Feb. 24, 2015 | 04:57AM EST
  19. MannKind Adds To Wednesday's Gains, Back Above $7

    Benzinga | Feb. 5, 2015 | 11:44AM EST
  20. Another Reason MannKind Could Be Up (In 1 Tweet)

    Benzinga | Jan. 26, 2015 | 16:15PM EST
  21. 10 Biotech Stories You Might've Missed This Week

    Benzinga | Jan. 15, 2015 | 13:18PM EST
  22. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 3

    Benzinga | Jan. 13, 2015 | 10:58AM EST
  23. Griffin Securities Analyst Thinks New MannKind Management Will Focus On R&D, Not Sanofi Merger

    Benzinga | Jan. 12, 2015 | 15:44PM EST
  24. Why The New MannKind Management Could Focus On R&D, Not A Potential Sanofi Merger

    Benzinga | Jan. 12, 2015 | 15:44PM EST
  25. MannKind Founder Becomes Chairman, President Hakan Edstrom Becomes New CEO

    Benzinga | Jan. 12, 2015 | 08:26AM EST
  26. What to Watch for: November 3-7

    GuruFocus | Nov. 4, 2014 | 11:39AM EST
  27. Earnings Scheduled For November 3, 2014

    Benzinga | Nov. 3, 2014 | 05:18AM EST
  28. NASDAQ Dips 1.5%; HB Fuller Shares Decline On Downbeat Results

    Benzinga | Sep. 25, 2014 | 12:09PM EST
  29. Markets Tumble; Scholastic Posts Wider Fiscal-First Quarter Loss

    Benzinga | Sep. 25, 2014 | 11:12AM EST
  30. Benzinga's Top Initiations

    Benzinga | Aug. 27, 2014 | 09:26AM EST
  31. Jefferies Initiates MannKind At Buy, Shares Rise

    Benzinga | Aug. 27, 2014 | 08:23AM EST
  32. Roche to Acquire InterMune and Deliver Hope to Patients Worldwide

    GuruFocus | Aug. 25, 2014 | 11:16AM EST
  33. Evaluating MannKind (MNKD) & Sanofi (SNY) Agreement for Afrezza

    GuruFocus | Aug. 15, 2014 | 09:59AM EST
  34. There is a Tide in the Affairs of MannKind: When Taken At the Flood, Will Lead to Fortune

    GuruFocus | Aug. 14, 2014 | 16:38PM EST
  35. Zynga Goes Out To Pasture; Kinder Morgan Combines Companies

    Benzinga | Aug. 11, 2014 | 14:51PM EST
  36. Dean Foods Dips On Q2 Results; Kinder Morgan Shares Spike Higher

    Benzinga | Aug. 11, 2014 | 12:44PM EST
  37. Markets Open Higher; Priceline Issues Downbeat Profit Forecast

    Benzinga | Aug. 11, 2014 | 11:32AM EST
  38. Stocks Higher, Nasdaq Leads; Kinder Morgan, Priceline Rising

    IBD | Aug. 11, 2014 | 10:31AM EST
  39. Morning Market Movers

    Benzinga | Aug. 11, 2014 | 09:45AM EST
  40. MannKind Up 20% On Diabetes Deal With Sanofi

    Benzinga | Aug. 11, 2014 | 09:18AM EST
  41. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 11, 2014 | 08:05AM EST
  42. US Stock Futures Signal Higher Start On Wall Street

    Benzinga | Aug. 11, 2014 | 07:44AM EST
  43. Sanofi and MannKind Announce Global Licensing Agreement for Afrezza (insulin human) Rapid-Acting Inhaled Insulin

    Benzinga | Aug. 11, 2014 | 07:04AM EST
  44. What This Upcoming Monday Means For MannKind Shareholders

    GuruFocus | Aug. 8, 2014 | 19:32PM EST
  45. Morning Market Movers

    Benzinga | Aug. 6, 2014 | 09:47AM EST
  46. Osiris Stem Cells To Compliment Mannkind's Afrezza In Disrupting Diabetes Market

    GuruFocus | Jul. 29, 2014 | 17:50PM EST
  47. Mannkind Corporation: Safe Labeling, Incentivized Spirometry and Experts Votes of Confidence

    GuruFocus | Jul. 25, 2014 | 18:59PM EST
  48. Mannkind Corporation: Why Afrezza Would Completely Dominate The Insulin Market

    GuruFocus | Jul. 16, 2014 | 19:22PM EST
  49. A Look at Mannkind Corporation's True Value

    GuruFocus | Jul. 2, 2014 | 19:02PM EST
  50. Morning Market Losers

    Benzinga | Jul. 1, 2014 | 09:46AM EST
Trading Center